cefonicid

Small moleculeapproved

Approved

Jul 26, 1993

Cefonicid is a semi-synthetic broad-spectrum cephalosporin antibiotic resistant to beta-lactamases. Similarly to other cephalosporins, cefonicid exerts its antibacterial activity through the inhibition of the bacterial cell-wall synthesis. Its in vitro and in vivo activity against a wide range of Gram-positive and Gram-negative microorganisms is documented. — NCATS

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12
Mol. weight
542.58 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • (6r,7r)-7-{[(2r)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1h-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6r,7r)-7-{[(2r)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1h-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicid
  • cefonicido
  • cefonicido
  • cefonicid sodium
  • cefonicid sodium
  • cefonicid sodium
  • cefonicid sodium
  • cefonicidum
  • cefonicidum
  • monocid
  • monocid
  • monocid
  • monocid
  • monocid
  • monocid
  • monocid
  • sk&f-d-75073-z2
  • sk&f-d-75073-z2

Organizations

Marketing (3)

OrganizationOrg typeRelationshipDate
GlaxoSmithKlineFor profitMKTGJul 26, 1993
GlaxoSmithKlineFor profitNDA2
SmithKline BeckmanFor profitNDA